The COVID 19 IgMIgG Rapid Test Kits markets size, share, and revenue will be closely analyzed, with an a - Benzinga
253840 Stock | KRW 5,170 30.00 0.58% |
About 54% of Sugentech's investor base is interested to short. The analysis of current outlook of investing in Sugentech suggests that many traders are impartial regarding Sugentech's prospects. The current market sentiment, together with Sugentech's historical and current headlines, can help investors time the market. In addition, many technical investors use Sugentech stock news signals to limit their universe of possible portfolio assets.
Sugentech |
The COVID 19 IgMIgG Rapid Test Kits markets size, share, and revenue will be closely analyzed, with an a Benzinga
Read at news.google.com
Sugentech Fundamental Analysis
We analyze Sugentech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sugentech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sugentech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Sugentech is number one stock in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Sugentech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sugentech stock to make a market-neutral strategy. Peer analysis of Sugentech could also be used in its relative valuation, which is a method of valuing Sugentech by comparing valuation metrics with similar companies.
Peers
Sugentech Related Equities
Complementary Tools for Sugentech Stock analysis
When running Sugentech's price analysis, check to measure Sugentech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sugentech is operating at the current time. Most of Sugentech's value examination focuses on studying past and present price action to predict the probability of Sugentech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sugentech's price. Additionally, you may evaluate how the addition of Sugentech to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |